Table 3.
Cardiovascular risk | Framingham | Brazilian Guideline | PROCAM | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Low | Moderate | High | Low | Moderate | High | ||
DAD | Low | 210 | 0 | 0 | 126 | 85 | 0 | 210 | 0 | 0 |
Moderate | 56 | 6 | 5 | 28 | 29 | 10 | 65 | 2 | 0 | |
High and very high | 0 | 3 | 3 | 0 | 0 | 6 | 3 | 2 | 1 | |
Agreement | 77.4% | 56.7% | 75.3% | |||||||
Kappa | 0.23 | 0.14 | 0.07 | |||||||
95% CI | 0.07–0.39 | 0.02–0.25 | 0–0.26 |
DAD: Data Collection on Adverse Effects of Anti-HIV Drugs; PROCAM: Prospective Cardiovascular Münster; CI: confidence Interval.